Literature DB >> 24449033

SMART designs in observational studies of opioid therapy duration.

John W Jackson1, Joshua J Gagne.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 24449033      PMCID： PMC3930774          DOI： 10.1007/s11606-013-2725-5

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  8 in total

1.  Administrative and artificial censoring in censored regression models.

Authors:  M M Joffe
Journal:  Stat Med       Date:  2001-08-15       Impact factor: 2.373

2.  Marginal structural models and causal inference in epidemiology.

Authors:  J M Robins; M A Hernán; B Brumback
Journal:  Epidemiology       Date:  2000-09       Impact factor: 4.822

Review 3.  A systematic review of validated methods for identifying depression using administrative data.

Authors:  Lisa Townsend; James T Walkup; Stephen Crystal; Mark Olfson
Journal:  Pharmacoepidemiol Drug Saf       Date:  2012-01       Impact factor: 2.890

4.  Constructing inverse probability weights for marginal structural models.

Authors:  Stephen R Cole; Miguel A Hernán
Journal:  Am J Epidemiol       Date:  2008-08-05       Impact factor: 4.897

5.  Trends in long-term opioid therapy for noncancer pain among persons with a history of depression.

Authors:  Jennifer Brennan Braden; Mark D Sullivan; G Thomas Ray; Kathleen Saunders; Joseph Merrill; Michael J Silverberg; Carolyn M Rutter; Constance Weisner; Caleb Banta-Green; Cynthia Campbell; Michael Von Korff
Journal:  Gen Hosp Psychiatry       Date:  2009-08-27       Impact factor: 3.238

Review 6.  Opioid therapy for chronic pain in the United States: promises and perils.

Authors:  Mark D Sullivan; Catherine Q Howe
Journal:  Pain       Date:  2013-09-11       Impact factor: 6.961

7.  Prescription opioid analgesics increase the risk of depression.

Authors:  Jeffrey F Scherrer; Dragan M Svrakic; Kenneth E Freedland; Timothy Chrusciel; Sumitra Balasubramanian; Kathleen K Bucholz; Elizabeth V Lawler; Patrick J Lustman
Journal:  J Gen Intern Med       Date:  2013-10-29       Impact factor: 5.128

8.  SMARTer discontinuation trial designs for developing an adaptive treatment strategy.

Authors:  Daniel Almirall; Scott N Compton; Moira A Rynn; John T Walkup; Susan A Murphy
Journal:  J Child Adolesc Psychopharmacol       Date:  2012-10       Impact factor: 2.576
  8 in total
  2 in total

1.  SMART designs in observational studies.

Authors:  Jeffrey F Scherrer; Sumitra Balasubramanian; Kenneth E Freedland; Patrick J Lustman
Journal:  J Gen Intern Med       Date:  2014-07       Impact factor: 5.128

2.  Diagnostics for Confounding of Time-varying and Other Joint Exposures.

Authors:  John W Jackson
Journal:  Epidemiology       Date:  2016-11       Impact factor: 4.822
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.